USH1480H - Methods of using dyphylline for the promotion of hair growth - Google Patents
Methods of using dyphylline for the promotion of hair growth Download PDFInfo
- Publication number
- USH1480H USH1480H US08/164,600 US16460093A USH1480H US H1480 H USH1480 H US H1480H US 16460093 A US16460093 A US 16460093A US H1480 H USH1480 H US H1480H
- Authority
- US
- United States
- Prior art keywords
- dyphylline
- skin
- composition
- hair growth
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229960002819 diprophylline Drugs 0.000 title claims abstract description 58
- KSCFJBIXMNOVSH-UHFFFAOYSA-N dyphylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CC(O)CO)C=N2 KSCFJBIXMNOVSH-UHFFFAOYSA-N 0.000 title claims abstract description 58
- 238000000034 method Methods 0.000 title claims abstract description 43
- 230000003779 hair growth Effects 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 claims abstract description 91
- 230000000699 topical effect Effects 0.000 claims abstract description 30
- 241000124008 Mammalia Species 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000003974 emollient agent Substances 0.000 claims description 10
- 230000001105 regulatory effect Effects 0.000 claims description 10
- 239000012530 fluid Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 claims description 3
- 229960004039 finasteride Drugs 0.000 claims description 3
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 claims 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 24
- 201000004384 Alopecia Diseases 0.000 description 20
- 230000003676 hair loss Effects 0.000 description 18
- 210000004209 hair Anatomy 0.000 description 17
- 208000024963 hair loss Diseases 0.000 description 17
- 210000004761 scalp Anatomy 0.000 description 17
- 239000003995 emulsifying agent Substances 0.000 description 11
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000006071 cream Substances 0.000 description 9
- 210000003780 hair follicle Anatomy 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 230000033228 biological regulation Effects 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- -1 bars Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 241000282412 Homo Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 239000002453 shampoo Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 3
- 241000195940 Bryophyta Species 0.000 description 3
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 229960003632 minoxidil Drugs 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 235000011929 mousse Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 230000003797 telogen phase Effects 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- WPPOGHDFAVQKLN-UHFFFAOYSA-N N-Octyl-2-pyrrolidone Chemical compound CCCCCCCCN1CCCC1=O WPPOGHDFAVQKLN-UHFFFAOYSA-N 0.000 description 2
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 description 2
- 229960000978 cyproterone acetate Drugs 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 229940124563 hair growth stimulant Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 238000009941 weaving Methods 0.000 description 2
- ZWVMLYRJXORSEP-UHFFFAOYSA-N 1,2,6-Hexanetriol Chemical compound OCCCCC(O)CO ZWVMLYRJXORSEP-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- QAIGYXWRIHZZAA-UHFFFAOYSA-M 1-methylpyridin-1-ium;chloride Chemical compound [Cl-].C[N+]1=CC=CC=C1 QAIGYXWRIHZZAA-UHFFFAOYSA-M 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical class CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- ZIMGGGWCDYVHOY-UHFFFAOYSA-N 3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine Chemical compound N=C1N(O)C(N)=CC(N2CCCCC2)=N1 ZIMGGGWCDYVHOY-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical class OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 230000036621 balding Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- YSAVZVORKRDODB-WDSKDSINSA-N diethyl tartrate Chemical compound CCOC(=O)[C@@H](O)[C@H](O)C(=O)OCC YSAVZVORKRDODB-WDSKDSINSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- CNHQWLUGXFIDAT-UHFFFAOYSA-N dioctyl 2-hydroxybutanedioate Chemical compound CCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCC CNHQWLUGXFIDAT-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000031774 hair cycle Effects 0.000 description 1
- 230000009583 hair follicle growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229940060367 inert ingredients Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000037041 intracellular level Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940113096 isoceteth 20 Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 description 1
- ODFAPIRLUPAQCQ-UHFFFAOYSA-M sodium stearoyl lactylate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O ODFAPIRLUPAQCQ-UHFFFAOYSA-M 0.000 description 1
- 239000003724 sodium stearoyl-2-lactylate Substances 0.000 description 1
- 235000010956 sodium stearoyl-2-lactylate Nutrition 0.000 description 1
- IZWPGJFSBABFGL-GMFCBQQYSA-M sodium;2-[methyl-[(z)-octadec-9-enoyl]amino]ethanesulfonate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)N(C)CCS([O-])(=O)=O IZWPGJFSBABFGL-GMFCBQQYSA-M 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008227 sterile water for injection Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Definitions
- the subject invention relates to the field of regulating hair growth in mammalian skin. Specifically, the subject invention relates to methods for the promotion of hair growth in humans.
- minoxidil (6-(1-piperidinyl)-2,4-pyrimidinediamine 3-oxide), a potent antihypertensive agent, as a hair growth promoting agent
- minoxidil (6-(1-piperidinyl)-2,4-pyrimidinediamine 3-oxide)
- a potent antihypertensive agent as a hair growth promoting agent
- Another approach for "curing" hair loss involves a procedure of weaving synthetic or natural hair strands into the remaining hair strands of the subject. Such a procedure is time consuming, expensive and requires follow-up re-weavings as the weaves loosen and/or the subject's existing hair strands grow. Furthermore, such a procedure does not cure hair loss, but merely masks the condition.
- hair plugs Another approach for treating hair loss is the use of hair plugs. This procedure involves the transplantation of terminal hair follicles from regions of normal hair growth on the subject's scalp to regions of thinning or no hair growth on the scalp. The procedure is time consuming, expensive and can be painful. Furthermore, the transplanted plugs, at least in the early stages following transplantation, produce an unnatural look to the scalp.
- compositions for promoting hair growth and/or treating hair loss in mammalian skin or scalp are gentler and less irritating to the skin than existing compositions. It is also an object of the subject invention to provide methods for promoting hair growth and/or treating hair loss in mammalian skin or scalp.
- the subject invention involves dyphylline chemical name of dyphylline and compositions comprising dyphylline. Such a compound and compositions satisfy the need for an efficacious, easily administered agent for regulating hair growth, having little or no undesirable side effects.
- the subject invention is also directed to a method of regulating hair growth in a mammal (e.g., humans and domestic animals) susceptible to or suffering from hair loss, comprising application of a composition of the subject invention.
- compositions of the subject invention comprise a safe and effective amount of dyphylline and a pharmaceutically-acceptable carrier.
- compositions containing dyphylline exhibit the ability to regulate hair growth in mammalian skin and scalp, without undesirable side effects, such as skin irritation, commonly associated with known compositions for regulating hair growth. While the subject invention is not limited to any particular mode of action, it is believed that dyphylline may regulate hair growth by elevating intracellular level of cyclic adenosine monophosphate, via inhibiting phosphodiesterase and activating adenosine reception on all membrane. By phosphodiesterase inhibition which results in an increase in the level of intracellular cyclic adenosine monophosphate (cAMP). Reduction of cAMP levels in the hair follicle has been linked to alopecia or hair loss.
- cAMP cyclic adenosine monophosphate
- diphylline means a compound having the structure: ##STR1##
- cutaneous injection means introduction of a substance beneath or within the skin by a hypodermic needle; preferably proximate to the site of desired response.
- safety and effective amount means a sufficient amount of a compound or composition to significantly induce a positive modification in the condition being treated, but low enough to avoid serious side effects.
- pharmaceutically-acceptable means that drugs, medicaments or inert ingredients which the term describes are suitable for use in contact with the tissues of humans and lower animals without undue toxicity, incompatibility, instability, irritation, allergic response, and the like.
- cosmetically-acceptable means that ingredients which the term describes are suitable for use in contact with the skin of humans and lower animals without undue toxicity, incompatibility, instability, irritation, allergic response, and the like.
- regulating hair growth means increasing the rate of hair growth and/or inducing the formation of a greater number of hair strands, and/or increasing the diameter of the hair strand, and/or lengthening the hair strand, and/or changing the hair follicle from vellus to terminal, and/or converting follicles from telogen to anagen phase (thereby increasing the overall ratio of anagen phase follicles relative to telogen phase follicles) and/or preventing, retarding, or arresting the process of hair loss, and/or treating alopecias.
- vellus hair follicle means a hair follicle which produces a soft, short, and often colorless hair fiber.
- the size of the vellus follicle is considerably smaller than the terminal hair follicle. In an adult, vellus follicles can be found on the forehead (i.e., receding hair line area) and bald scalp beside other parts of the body.
- terminal follicle means a hair follicle which produces a coarse, long, and often pigmented hair follicle.
- the size of the terminal follicle is considerably larger, thicker in diameter and longer than the vellus follicle. In the adult, terminal follicles can be found on the scalp, axilla and pubic areas. (Chest and legs.)
- anagen phase refers to the period in the hair follicle growth cycle wherein the follicle is actively growing and a real hair strand is extending.
- telogen phase refers to the period in the hair growth cycle wherein the follicle is resting and hair strand cease extending.
- Compositions useful for regulating hair growth preferably comprise from about 0.005% to about 15% of dyphylline, more preferably from about 0.1% to about 10%, more preferably still from about 1% to about 5%, more preferably still from about 1% to about 3%.
- the Carrier is the Carrier
- compositions of the subject invention comprise a solid, semi-solid or liquid cosmetically and/or physiologically acceptable and/or pharmaceutically-acceptable carrier to enable dyphylline to be delivered to the desired target at an appropriate concentration.
- the carrier can itself be inert or it can possess cosmetic, physiological or pharmaceutical benefits of its own.
- the nature of the carrier will be dictated by the method chosen for administration of the composition.
- the method of administration of dyphylline composition may range from internal methods such as injection to external topical methods.
- a preferred method of administration of dyphylline is by cutaneous injection.
- the carrier for facilitation of such administration would preferably comprise water or a saline solution, preferably an isotonic saline solution.
- Topical application is preferably achieved with compositions in the forms of lotions, solutions, ointments, sprays, tonics, creams, bars, shampoos, cream rinses, gels, sticks, mousse, pastes and the like.
- Topical compositions of the subject invention can be formulated as liquids, for example as a lotion, shampoo, conditioner, mousse or milk.
- Such liquid compositions may be formulated for use in conjunction with an applicator such as a roll-ball applicator, a tined applicator, a pad applicator, or a spray device such as an aerosol can containing propellant, or a container fitted with a pump to dispense the liquid product, or a liquid-impregnated fabric, such as a tissue wipe.
- compositions of the invention can be solid or semi-solid, for example sticks, creams or gels.
- Such solid or semi-solid compositions may be formulated for use in conjunction with a suitable applicator or simply a tube, jar or other convenient container.
- Suitable vehicles can be classified as described hereinafter.
- Topical carrier refers to substances which can act as diluents, dispersants, or solvents for dyphylline which therefore ensure that it can be applied to and distributed evenly over the selected target at an appropriate concentration.
- the carrier is preferably one which can aid penetration of dyphylline into the skin to reach the immediate environment of the hair follicle.
- Topical carriers useful in compositions of the subject invention can include water as a vehicle, and/or at least one cosmetically acceptable vehicle other than water.
- Carriers useful in topical compositions according to the invention may include liposomes, latex latices, microspheres, cyclodextrins and various forms of microencapsulation of dyphylline.
- a preferred amount of penetration enhancing agent is from about 1% to about 5% of the composition.
- the carrier is either organic in nature or an aqueous emulsion and capable of having dyphylline dispersed or dissolved therein.
- the carrier may include pharmaceutically-acceptable emollients, skin penetration enhancers, coloring agents, fragrances, emulsifiers, thickening agents, and solvents.
- Topical compositions of the subject invention may be formulated as a composition comprising an emollient.
- Such compositions typically comprise from about 1% to about 50%, preferably from about 5% to about 20% of a topical pharmaceutically-acceptable emollient; and a safe and effective amount of dyphylline.
- emollients refer to materials used for the prevention or relief of dryness, as well as for the protection of the skin.
- suitable emollients include, but are not limited to, hydrocarbon oils and waxes, silicon oils, triglyceride fats and oils, acetoglyceride esters, ethoxylated glycerides, alkyl esters of fatty acids having 10 to 20 carbon atoms, alkenyl esters of fatty acids having 10 to 20 carbon atoms, fatty acids having 8-22 carbon atoms, fatty alcohols having 8-22 carbon atoms, fatty alcohol ethers, ether-esters, lanolin and derivatives, polyhydric alcohols and polyether derivatives, wax esters, beeswax derivatives, vegetable waxes, phospholipids, sterols, and amides.
- Topical compositions of the subject invention may also be formulated as a cream.
- the creams of the present invention comprise a safe and effective amount of dyphylline; from about 1% to about 50%, preferably from about 5% to about 25%, of an emollient; and from about 25% to about 95% water.
- the cream form contains a suitable emulsifier.
- an emulsifier When an emulsifier is included, it is in the composition at a level from about 1% to about 25%, preferably from about 3% to about 10%.
- Emulsifiers may be nonionic, anionic or cationic. Suitable emulsifiers are disclosed in, for example, U.S. Pat. No. 3,755,560, issued Aug.
- emulsifiers are anionic or nonionic.
- Topical compositions of the subject invention may also be formulated as a composition comprising a lotion.
- the lotions of the subject invention comprise a safe and effective amount of dyphylline; from about 1% to about 50%, preferably from about 3% to about 15% of an emollient; and from about 45% to about 85%, preferably from about 50% to about 75% water.
- the lotion form may contain a suitable emulsifier, comprising from about 1% to about 50%, preferably from about 3% to about 10% of the composition.
- suitable emulsifiers are included hereinabove in the disclosure of cream formulations.
- a solution form of the present invention comprises a safe and effective amount of dyphylline, water and a suitable organic solvent.
- suitable organic materials useful as the solvent or a part of a solvent system are as follows: propylene glycol, dimethyl isosorbide, N-octyl pyrrolidone, glycerin, polyethylene glycol (M.W. 200-600), polypropylene glycol (M.W. 425-2025), sorbitol esters, 1,2,6-hexanetriol, ethanol, isopropanol, diethyl tartrate, butanediol, and mixtures thereof.
- Gel compositions of the present invention can be formulated by simply mixing a suitable thickening agent to the previously described solution compositions.
- the gel compositions preferably comprise a safe and effective amount of dyphylline; from about 5% to about 75%, preferably from about 10% to about 50%, of an organic solvent as previously described for solutions; and from about 0.1% to about 10%, preferably from about 0.5% to about 5% of the thickening agent.
- compositions of solid forms of the present invention have use as stick-type compositions intended for application to scalp or other parts of the body.
- Such compositions preferably comprise a safe and effective amount of dyphylline, and from about 50% to about 98%, preferably from about 60% to about 90%, of the previously described emollients.
- Such compositions can further comprise from about 1% to about 20%, preferably from about 5% to about 15%, of a suitable thickening agent, and optionally emulsifiers and water.
- Scalp cleaning compositions useful in hair growth regulation comprise, in addition to dyphylline, a cosmetically-acceptable surfactant.
- the cleaning compositions useful in the subject invention preferably contain a safe and effective amount of dyphylline and preferably from about 1% to about 90%, more preferably from about 5% to about 10%, of a cosmetically-acceptable surfactant.
- the physical form of the cleansing compositions is not critical.
- the compositions can be, for example, formulated as toilet bars, liquids, shampoos, pastes, or mousses.
- Rinse-off cleansing compositions, such as shampoos require a delivery system adequate to deposit an effective amount of dyphylline to the scalp.
- a preferred delivery system involves the use of insoluble complexes.
- the surfactant component of the compositions useful in the subject invention are selected from anionic, nonionic, zwitterionic, amphoteric and ampholytic surfactants, as well as mixtures of these surfactants.
- Such surfactants are well-known to those skilled in the detergency art.
- the cleaning compositions useful in the subject invention can optionally contain, at their ann-established levels, materials which are conventionally used in cleansing compositions.
- Nonlimiting examples of possible surfactants include isoceteth-20, sodium methyl cocoyl taurate, sodium methyl oleoyl taurate, and sodium lauryl sulfate. See U.S. Pat. No. 4,800,197, to Kowcz et al., issued Jan. 24, 1989, which is incorporated herein by reference in its entirety. Examples of a broad variety of additional surfactants useful herein are described in McCutcheon's, DETERGENTS AND EMULSIFIERS, North American Edition (1986), published by Allured Publishing Corporation, which is incorporated herein by reference in its entirety.
- compositions of the subject invention useful for regulating hair growth may also optionally comprise other hair growth stimulants capable of functioning in different ways to enhance the benefit of dyphylline.
- hair growth stimulants capable of functioning in different ways to enhance the benefit of dyphylline.
- An example of such a substance includes, but is not limited to minoxidil, and derivatives thereof, as disclosed in U.S. Pat. Nos., 3,461,461; 3,973,061; 3,464,987; and 4,139,619; incorporated herein by reference.
- Additional hair growth stimulants useful in compositions of the subject invention comprising dyphylline include the agents disclosed by the following, which are all incorporated herein by reference: U.S. Pat. No. 5,215,760, Kavoussi and Kavoussi, issued Jun. 1, 1993; U.S. Pat. No. 5,192,534, Grollier and Richoux, issued Mar. 9, 1993; U.S. Pat. No. 5,178,883, Knighton, issued Jan. 12, 1993; U.S. Pat. No. 5,177,061, Pickart, issued Jan. 5, 1993; U.S. Pat. No. 5,130,142, Wong and Warren, issued Jul. 14, 1992; U.S. Pat. No.
- compositions useful for the methods of the instant invention can be delivered from a variety of delivery devices.
- compositions useful herein can be incorporated into a medicated cleansing pad.
- these pads comprise from about 50% to about 75% by weight of one or more layers of nonwoven fabric material and from about 20% to about 50% by weight of a liquid composition deliverable from the nonwoven fabric material preferably comprising from about 0.01% to about 10% dyphylline, more preferably from about 0.5% to about 5% dyphylline, more preferably still from about 1% to about 3%.
- a liquid composition deliverable from the nonwoven fabric material preferably comprising from about 0.01% to about 10% dyphylline, more preferably from about 0.5% to about 5% dyphylline, more preferably still from about 1% to about 3%.
- compositions useful herein can also be incorporated into and delivered from a soft-tipped or flexible dispensing device.
- These devices are useful for the controlled delivery of the compositions to the skin or scalp surface and have the advantage that the treatment composition itself never need be directly handled by the user.
- Nonlimiting examples of these devices comprise a fluid container including a mouth, an applicator, means for holding the applicator in the mouth of the container, and a normally closed pressure-responsive valve for permitting the flow of fluid from the container to the applicator upon the application of pressure to the valve.
- the fluid preferably contains from about 0.005% to about 15% dyphylline, more preferably from about 0.5% to about 3% dyphylline, more preferably still from about 1% to about 3%.
- the valve can include a diaphragm formed from an elastically fluid impermeable material with a plurality of non-intersecting arcuate slits therein, where each slit has a base which is intersected by at least one other slit, and where each slit is out of intersecting relation with its own base, and wherein there is a means for disposing the valve in the container inside of the applicator.
- Examples of these applicator devices are described in U.S. Pat. No. 4,693,623, to Schwartzman, issued Sep. 15, 1987; U.S. Pat. No. 4,620,648, to Schwartzman, issued Sep. 15, 1987; U.S. Pat. No. 3,669,323, to Harker et at., issued Jun.
- the subject invention provides for the use of dyphylline for preventing hair loss. Such prophylactic application is particularly useful to individuals who have a family history of baldness.
- the subject invention provides for the use of dyphylline for stimulating new hair growth.
- dyphylline is applied to mammals in need of hair growth regulation, more preferably to mammals suffering from hair loss. The following methods of use may be used to regulate hair growth.
- compositions according to the invention are preferably intended for application by cutaneous injection.
- the amount of the composition and the frequency of cutaneous injection can vary widely, depending on personal needs.
- a composition suitable for cutaneous injection comprising dyphylline be cutaneously injected preferably from about once per day to about once every six months, more preferably from about twice per week to about twice per month.
- the composition for cutaneous injection will preferably administer from about 0.01 to about 1 mg of dyphylline per cm 2 skin receiving cutaneous injection, more preferably from about 0.02 to about 0.5 mg/cm 2 , more preferably still from about 0.05 to about 0.1 mg/cm 2 .
- the period of injections would be over a period of from about one month to the life of the subject, more preferably, in the case of humans, from about 1 month to about ten years, more preferably from about three months to about two years, more preferably still from about six months to about one year, thereby resulting in regulation of hair growth.
- a more preferred method of applying the compositions according to the subject invention involves topical application to the scalp of a human subject or the skin of a domesticated animal subject to regulate hair growth, particularly where the scalp/skin is already bald or balding.
- the amount of the composition and the frequency of application to the hair and/or scalp/skin can vary widely, depending on the desired effect and/or personal needs, but it is suggested as an example that topical application preferably range from about 1 to about 10 times daily, more preferably from about 1 to about 6 times daily, more preferably still from about 1 to about 3 times daily, and most preferably about once per day.
- composition for topical application will preferably contain from about 0.01 to about 1,000 ⁇ g of dyphylline per cm 2 skin receiving the topical composition, more preferably from about 0.1 to about 600 ⁇ g/cm 2 , more preferably still from about 1 to about 300 ⁇ g/cm 2 , more preferably from about 100 to about 300 ⁇ g/cm 2 .
- the period of topical application may be over the subject's life, but would preferably, in the case of a human subject, be over a period of from about one month to about ten years, more preferably from about three months to about two years, more preferably still from about six months to about one year, thereby resulting in regulation of hair growth.
- hair growth regulation is achieved by topical administration of a composition of the subject invention and oral administration of an antiandrogen (e.g., finasteride, cyproterone acetate) during the same treatment period.
- an antiandrogen e.g., finasteride, cyproterone acetate
- composition embodiments of the subject invention are illustrated in the following examples. All parts, percentages, and ratios used herein are by weight unless otherwise specified.
- An injectable composition is prepared by combining the following components utilizing conventional mixing techniques.
- composition per cm 2 skin is injected at the site of desired hair regulation once every two weeks for six months to a subject resulting in new hair growth.
- the following topical solutions are prepared by combining the following components utilizing conventional mixing techniques.
- 1000 mg of the composition per 100 cm 2 skin is topically applied twice per day for one year to a subject resulting in new hair growth.
- the following conditioning lotions are prepared by combining the following components utilizing conventional mixing techniques.
- 1000 mg of the composition per 100 cm 2 skin is topically applied once per day for 6 months to a subject resulting in prevention of hair loss.
- the following shampoo compositions are prepared by combining the following components utilizing conventional mixing techniques.
- This composition may be used in a conventional manner for cleaning hair, while bestowing hair growth regulation to the subject. From about 0.1 g to about 10 g of the composition is applied to hair that has been wetted, generally with water, worked through the hair and then rinsed out.
- the following topical solutions are prepared by combining the following components utilizing conventional mixing techniques.
- 1000 mg of the composition per 100 cm 2 of skin is topically applied once per day for six months to a subject resulting in new hair growth.
- the following vanishing creams are prepared by combining the following components utilizing conventional mixing techniques.
- 1000 mg of the composition per 100 cm 2 skin is topically applied twice per day for six months to a subject resulting in new hair growth.
- the following penetrating creams are prepared by combining the following components utilizing conventional mixing techniques.
- 1000 mg of the composition per 100 cm 2 ski is topically applied once per day for one year to a subject resulting in new hair growth.
- the following ion pair oil-in-water emulsions are prepared by combining the following components utilizing conventional mixing techniques.
- 1000 mg of the composition per 100 cm 2 of the skin is topically applied twice per day for six months to a subject resulting in new hair growth.
- liposomal dispersions are prepared by combining the following components utilizing conventional mixing techniques.
- the reagents are blended to produce unilamillar or multilamellar vesicles by methods known to those skilled in the art.
- the resulting dispersions are either directly applied topically to the scalp (100 mg of composition per 100 cm 2 of skin) or are blended into a suitable oil-in-water emulsion carrier, e.g, those in Examples V-VII, XIV, XVI, XVIII-XX at a level of about 1-25% (w/w) and then applied topically to the scalp at a comparable dosage level.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
The subject invention relates to methods for promoting hair growth in mammals comprising topical application of dyphylline or a pharmaceutically-acceptable salt thereof. The subject invention further involves topical compositions comprising dyphylline.
Description
The subject invention relates to the field of regulating hair growth in mammalian skin. Specifically, the subject invention relates to methods for the promotion of hair growth in humans.
Society in general continues to attach a stigma to hair loss. Men and women suffer from hair loss, often resulting in self-consciousness relating to the hair loss. Domestic animals, such as cats and dogs, also suffer from hair loss. While the animal is not likely to be emotionally affected by such hair loss, its owner may be, particularly if such an animal is to be shown in various competitions. Additionally, increased hair growth in livestock such as sheep, thereby resulting in increased wool production, is also desirable. The desire for a healthy full head (or body, in the case of animals) of hair has resulted in a variety of approaches to the "curing" of hair loss.
One such approach involves the much publicized use of minoxidil (6-(1-piperidinyl)-2,4-pyrimidinediamine 3-oxide), a potent antihypertensive agent, as a hair growth promoting agent (see U.S. Pat. Nos., 3,461,461; 3,973,061; 3,464,987; and 4,139,619). Unfortunately, not all people respond to minoxidil and the efficacy level is limited in those individuals exhibiting a response.
Another approach for "curing" hair loss involves a procedure of weaving synthetic or natural hair strands into the remaining hair strands of the subject. Such a procedure is time consuming, expensive and requires follow-up re-weavings as the weaves loosen and/or the subject's existing hair strands grow. Furthermore, such a procedure does not cure hair loss, but merely masks the condition.
Another approach for treating hair loss is the use of hair plugs. This procedure involves the transplantation of terminal hair follicles from regions of normal hair growth on the subject's scalp to regions of thinning or no hair growth on the scalp. The procedure is time consuming, expensive and can be painful. Furthermore, the transplanted plugs, at least in the early stages following transplantation, produce an unnatural look to the scalp.
For the foregoing reasons, there is a need for an easily administered, efficacious agent for treating hair loss in a mammal having little or no undesirable side effects. It is an object of the subject invention to provide topical compositions for promoting hair growth and/or treating hair loss in mammalian skin or scalp. It is a further object of the subject invention to provide such compositions which are gentler and less irritating to the skin than existing compositions. It is also an object of the subject invention to provide methods for promoting hair growth and/or treating hair loss in mammalian skin or scalp.
The subject invention involves dyphylline chemical name of dyphylline and compositions comprising dyphylline. Such a compound and compositions satisfy the need for an efficacious, easily administered agent for regulating hair growth, having little or no undesirable side effects. The subject invention is also directed to a method of regulating hair growth in a mammal (e.g., humans and domestic animals) susceptible to or suffering from hair loss, comprising application of a composition of the subject invention.
The compositions of the subject invention comprise a safe and effective amount of dyphylline and a pharmaceutically-acceptable carrier.
These and other features, aspects and advantages of the subject invention will become better understood with reference to the following description and appended claims.
It has been found that compositions containing dyphylline exhibit the ability to regulate hair growth in mammalian skin and scalp, without undesirable side effects, such as skin irritation, commonly associated with known compositions for regulating hair growth. While the subject invention is not limited to any particular mode of action, it is believed that dyphylline may regulate hair growth by elevating intracellular level of cyclic adenosine monophosphate, via inhibiting phosphodiesterase and activating adenosine reception on all membrane. By phosphodiesterase inhibition which results in an increase in the level of intracellular cyclic adenosine monophosphate (cAMP). Reduction of cAMP levels in the hair follicle has been linked to alopecia or hair loss.
As used herein, "dyphylline" means a compound having the structure: ##STR1##
As used herein, "topical application" means directly laying on or spreading on outer skin.
As used herein, "cutaneous injection" means introduction of a substance beneath or within the skin by a hypodermic needle; preferably proximate to the site of desired response.
As used herein, "safe and effective amount" means a sufficient amount of a compound or composition to significantly induce a positive modification in the condition being treated, but low enough to avoid serious side effects.
As used herein, "comprising" means that other steps and other ingredients which do not affect the end result can be added. This term encompasses the terms "consisting of" and "consisting essentially of".
As used herein, "pharmaceutically-acceptable" means that drugs, medicaments or inert ingredients which the term describes are suitable for use in contact with the tissues of humans and lower animals without undue toxicity, incompatibility, instability, irritation, allergic response, and the like.
As used herein, "cosmetically-acceptable" means that ingredients which the term describes are suitable for use in contact with the skin of humans and lower animals without undue toxicity, incompatibility, instability, irritation, allergic response, and the like.
As used herein, "regulating hair growth" means increasing the rate of hair growth and/or inducing the formation of a greater number of hair strands, and/or increasing the diameter of the hair strand, and/or lengthening the hair strand, and/or changing the hair follicle from vellus to terminal, and/or converting follicles from telogen to anagen phase (thereby increasing the overall ratio of anagen phase follicles relative to telogen phase follicles) and/or preventing, retarding, or arresting the process of hair loss, and/or treating alopecias.
As used herein, "vellus hair follicle" means a hair follicle which produces a soft, short, and often colorless hair fiber. The size of the vellus follicle is considerably smaller than the terminal hair follicle. In an adult, vellus follicles can be found on the forehead (i.e., receding hair line area) and bald scalp beside other parts of the body.
As used herein, "terminal follicle" means a hair follicle which produces a coarse, long, and often pigmented hair follicle. The size of the terminal follicle is considerably larger, thicker in diameter and longer than the vellus follicle. In the adult, terminal follicles can be found on the scalp, axilla and pubic areas. (Chest and legs.)
As used herein, "anagen phase" refers to the period in the hair follicle growth cycle wherein the follicle is actively growing and a real hair strand is extending.
As used herein, "telogen phase" refers to the period in the hair growth cycle wherein the follicle is resting and hair strand cease extending.
Compositions useful for regulating hair growth preferably comprise from about 0.005% to about 15% of dyphylline, more preferably from about 0.1% to about 10%, more preferably still from about 1% to about 5%, more preferably still from about 1% to about 3%.
The Carrier
The compositions of the subject invention comprise a solid, semi-solid or liquid cosmetically and/or physiologically acceptable and/or pharmaceutically-acceptable carrier to enable dyphylline to be delivered to the desired target at an appropriate concentration. The carrier can itself be inert or it can possess cosmetic, physiological or pharmaceutical benefits of its own. The nature of the carrier will be dictated by the method chosen for administration of the composition. The method of administration of dyphylline composition may range from internal methods such as injection to external topical methods.
A preferred method of administration of dyphylline is by cutaneous injection. The carrier for facilitation of such administration would preferably comprise water or a saline solution, preferably an isotonic saline solution.
A more preferred method of administration of dyphylline is by topical application. Topical application is preferably achieved with compositions in the forms of lotions, solutions, ointments, sprays, tonics, creams, bars, shampoos, cream rinses, gels, sticks, mousse, pastes and the like.
Topical compositions of the subject invention can be formulated as liquids, for example as a lotion, shampoo, conditioner, mousse or milk. Such liquid compositions may be formulated for use in conjunction with an applicator such as a roll-ball applicator, a tined applicator, a pad applicator, or a spray device such as an aerosol can containing propellant, or a container fitted with a pump to dispense the liquid product, or a liquid-impregnated fabric, such as a tissue wipe.
Alternatively, the compositions of the invention can be solid or semi-solid, for example sticks, creams or gels. Such solid or semi-solid compositions may be formulated for use in conjunction with a suitable applicator or simply a tube, jar or other convenient container.
The selection of a carrier for this purpose subjects a wide range of possibilities depending on the required product form of the composition. Suitable vehicles can be classified as described hereinafter.
The term "topical carrier" refers to substances which can act as diluents, dispersants, or solvents for dyphylline which therefore ensure that it can be applied to and distributed evenly over the selected target at an appropriate concentration. The carrier is preferably one which can aid penetration of dyphylline into the skin to reach the immediate environment of the hair follicle. Topical carriers useful in compositions of the subject invention can include water as a vehicle, and/or at least one cosmetically acceptable vehicle other than water. Carriers useful in topical compositions according to the invention may include liposomes, latex latices, microspheres, cyclodextrins and various forms of microencapsulation of dyphylline. A preferred amount of penetration enhancing agent is from about 1% to about 5% of the composition.
Generally, the carrier is either organic in nature or an aqueous emulsion and capable of having dyphylline dispersed or dissolved therein. The carrier may include pharmaceutically-acceptable emollients, skin penetration enhancers, coloring agents, fragrances, emulsifiers, thickening agents, and solvents.
Topical compositions of the subject invention may be formulated as a composition comprising an emollient. Such compositions typically comprise from about 1% to about 50%, preferably from about 5% to about 20% of a topical pharmaceutically-acceptable emollient; and a safe and effective amount of dyphylline.
As used herein, "emollients" refer to materials used for the prevention or relief of dryness, as well as for the protection of the skin. A wide variety of suitable emollients are known and may be used herein. Such emollients include, but are not limited to, hydrocarbon oils and waxes, silicon oils, triglyceride fats and oils, acetoglyceride esters, ethoxylated glycerides, alkyl esters of fatty acids having 10 to 20 carbon atoms, alkenyl esters of fatty acids having 10 to 20 carbon atoms, fatty acids having 8-22 carbon atoms, fatty alcohols having 8-22 carbon atoms, fatty alcohol ethers, ether-esters, lanolin and derivatives, polyhydric alcohols and polyether derivatives, wax esters, beeswax derivatives, vegetable waxes, phospholipids, sterols, and amides. SAGARIN, COSMETICS, SCIENCE AND TECHNOLOGY, 2nd Edition, Vol. 1, pp. 32-43 (1972), incorporated herein by reference, contains numerous examples of suitable materials.
Topical compositions of the subject invention may also be formulated as a cream. Preferably the creams of the present invention comprise a safe and effective amount of dyphylline; from about 1% to about 50%, preferably from about 5% to about 25%, of an emollient; and from about 25% to about 95% water. Optionally the cream form contains a suitable emulsifier. When an emulsifier is included, it is in the composition at a level from about 1% to about 25%, preferably from about 3% to about 10%. Emulsifiers may be nonionic, anionic or cationic. Suitable emulsifiers are disclosed in, for example, U.S. Pat. No. 3,755,560, issued Aug. 28, 1973, Diekert et al.; U.S. Pat. No. 4,421,769,issued Dec. 20, 1983, Dixon et al.; and McCutheon's Detergents and Emulsifiers, North American Edition, pp. 317-324 (1986); the disclosures of which are incorporated herein by reference. Preferred emulsifiers are anionic or nonionic.
Topical compositions of the subject invention may also be formulated as a composition comprising a lotion. Preferably the lotions of the subject invention comprise a safe and effective amount of dyphylline; from about 1% to about 50%, preferably from about 3% to about 15% of an emollient; and from about 45% to about 85%, preferably from about 50% to about 75% water. Optionally, the lotion form may contain a suitable emulsifier, comprising from about 1% to about 50%, preferably from about 3% to about 10% of the composition. Example of suitable emulsifiers are included hereinabove in the disclosure of cream formulations.
Preferably a solution form of the present invention comprises a safe and effective amount of dyphylline, water and a suitable organic solvent. Suitable organic materials useful as the solvent or a part of a solvent system are as follows: propylene glycol, dimethyl isosorbide, N-octyl pyrrolidone, glycerin, polyethylene glycol (M.W. 200-600), polypropylene glycol (M.W. 425-2025), sorbitol esters, 1,2,6-hexanetriol, ethanol, isopropanol, diethyl tartrate, butanediol, and mixtures thereof.
Gel compositions of the present invention can be formulated by simply mixing a suitable thickening agent to the previously described solution compositions. The gel compositions preferably comprise a safe and effective amount of dyphylline; from about 5% to about 75%, preferably from about 10% to about 50%, of an organic solvent as previously described for solutions; and from about 0.1% to about 10%, preferably from about 0.5% to about 5% of the thickening agent.
Compositions of solid forms of the present invention have use as stick-type compositions intended for application to scalp or other parts of the body. Such compositions preferably comprise a safe and effective amount of dyphylline, and from about 50% to about 98%, preferably from about 60% to about 90%, of the previously described emollients. Such compositions can further comprise from about 1% to about 20%, preferably from about 5% to about 15%, of a suitable thickening agent, and optionally emulsifiers and water.
Scalp cleaning compositions useful in hair growth regulation, comprise, in addition to dyphylline, a cosmetically-acceptable surfactant. The cleaning compositions useful in the subject invention preferably contain a safe and effective amount of dyphylline and preferably from about 1% to about 90%, more preferably from about 5% to about 10%, of a cosmetically-acceptable surfactant.
The physical form of the cleansing compositions is not critical. The compositions can be, for example, formulated as toilet bars, liquids, shampoos, pastes, or mousses. Rinse-off cleansing compositions, such as shampoos, require a delivery system adequate to deposit an effective amount of dyphylline to the scalp. A preferred delivery system involves the use of insoluble complexes. For a more complete disclosure, see U.S. Pat. No. 4,835,148, Barford et al., issued May 30, 1989; incorporated herein by reference in its entirety.
The surfactant component of the compositions useful in the subject invention are selected from anionic, nonionic, zwitterionic, amphoteric and ampholytic surfactants, as well as mixtures of these surfactants. Such surfactants are well-known to those skilled in the detergency art.
The cleaning compositions useful in the subject invention can optionally contain, at their ann-established levels, materials which are conventionally used in cleansing compositions. Nonlimiting examples of possible surfactants include isoceteth-20, sodium methyl cocoyl taurate, sodium methyl oleoyl taurate, and sodium lauryl sulfate. See U.S. Pat. No. 4,800,197, to Kowcz et al., issued Jan. 24, 1989, which is incorporated herein by reference in its entirety. Examples of a broad variety of additional surfactants useful herein are described in McCutcheon's, DETERGENTS AND EMULSIFIERS, North American Edition (1986), published by Allured Publishing Corporation, which is incorporated herein by reference in its entirety.
Combination Actives
The compositions of the subject invention useful for regulating hair growth may also optionally comprise other hair growth stimulants capable of functioning in different ways to enhance the benefit of dyphylline. An example of such a substance includes, but is not limited to minoxidil, and derivatives thereof, as disclosed in U.S. Pat. Nos., 3,461,461; 3,973,061; 3,464,987; and 4,139,619; incorporated herein by reference.
Additional hair growth stimulants useful in compositions of the subject invention comprising dyphylline include the agents disclosed by the following, which are all incorporated herein by reference: U.S. Pat. No. 5,215,760, Kavoussi and Kavoussi, issued Jun. 1, 1993; U.S. Pat. No. 5,192,534, Grollier and Richoux, issued Mar. 9, 1993; U.S. Pat. No. 5,178,883, Knighton, issued Jan. 12, 1993; U.S. Pat. No. 5,177,061, Pickart, issued Jan. 5, 1993; U.S. Pat. No. 5,130,142, Wong and Warren, issued Jul. 14, 1992; U.S. Pat. No. 5,068,315, Buultjens, Colin, Jahoda and Oliver, issued Nov. 26, 1991; U.S. Pat. No. 5,091,173, Buultjens, Hellens, Oliver and Withers, issued Feb. 25, 1992; U.S. Pat. No. 5,037,643, Green, issued Aug. 6, 1991; U.S. Pat. No. 4,975,441, Gibson, issued Dec. 4, 1990; U.S. Pat. No. 4,871,839, Gibson, issued Oct. 3, 1989; U.S. Pat. No. 4,832,946, Green, issued May 23, 1989; U.S. Pat. No. 4,761,401, Couchman, issued Aug. 2, 1988; U.S. Pat. No. 4,139,619, Chidsey, issued Feb. 13, 1979; U.S. Pat. No. 3,466,364, Takahashi, issued Sep. 9, 1969; and U.S. Pat. No. 1,732,120, Christen, issued Oct. 15, 1929; PROSCAR™ (a.k.a., finasteride or (5α, 17β)-1-1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide; Merck & Co.) see THE MERCK INDEX, 11th Ed., p. 1250, entry 7888; and cyproterone acetate, see THE MERCK INDEX, 11 th Ed., p. 435, entry 2781.
Delivery Methods for Topical Compositions
The topical compositions useful for the methods of the instant invention can be delivered from a variety of delivery devices. The following are two nonlimiting examples.
The compositions useful herein can be incorporated into a medicated cleansing pad. Preferably these pads comprise from about 50% to about 75% by weight of one or more layers of nonwoven fabric material and from about 20% to about 50% by weight of a liquid composition deliverable from the nonwoven fabric material preferably comprising from about 0.01% to about 10% dyphylline, more preferably from about 0.5% to about 5% dyphylline, more preferably still from about 1% to about 3%. These pads are described in detail in U.S. Pat. Nos. 4,891,228, to Thaman et al., issued Jan. 2, 1990; and 4,891,227, to Thaman et al., issued Jan. 2, 1990; both of which are incorporated by reference.
The compositions useful herein can also be incorporated into and delivered from a soft-tipped or flexible dispensing device. These devices are useful for the controlled delivery of the compositions to the skin or scalp surface and have the advantage that the treatment composition itself never need be directly handled by the user. Nonlimiting examples of these devices comprise a fluid container including a mouth, an applicator, means for holding the applicator in the mouth of the container, and a normally closed pressure-responsive valve for permitting the flow of fluid from the container to the applicator upon the application of pressure to the valve. The fluid preferably contains from about 0.005% to about 15% dyphylline, more preferably from about 0.5% to about 3% dyphylline, more preferably still from about 1% to about 3%.
The valve can include a diaphragm formed from an elastically fluid impermeable material with a plurality of non-intersecting arcuate slits therein, where each slit has a base which is intersected by at least one other slit, and where each slit is out of intersecting relation with its own base, and wherein there is a means for disposing the valve in the container inside of the applicator. Examples of these applicator devices are described in U.S. Pat. No. 4,693,623, to Schwartzman, issued Sep. 15, 1987; U.S. Pat. No. 4,620,648, to Schwartzman, issued Sep. 15, 1987; U.S. Pat. No. 3,669,323, to Harker et at., issued Jun. 13, 1972; U.S. Pat. No. 3,418,055, to Schwartzman, issued Dec. 24, 1968; and U.S. Pat. No. 3,410,645, to Schwartzman, issued Nov. 12, 1968; all of which are incorporated herein by reference. Examples of applicators useful herein are commercially available from Dab-O-Matic, Mount Vernon, N.Y.
Methods for Regulating Hair Growth
The subject invention provides for the use of dyphylline for preventing hair loss. Such prophylactic application is particularly useful to individuals who have a family history of baldness. In another embodiment, the subject invention provides for the use of dyphylline for stimulating new hair growth. Preferably, dyphylline is applied to mammals in need of hair growth regulation, more preferably to mammals suffering from hair loss. The following methods of use may be used to regulate hair growth.
The compositions according to the invention are preferably intended for application by cutaneous injection. The amount of the composition and the frequency of cutaneous injection can vary widely, depending on personal needs. As an example of application by cutaneous injection, it is suggested that a composition suitable for cutaneous injection comprising dyphylline be cutaneously injected preferably from about once per day to about once every six months, more preferably from about twice per week to about twice per month. The composition for cutaneous injection will preferably administer from about 0.01 to about 1 mg of dyphylline per cm2 skin receiving cutaneous injection, more preferably from about 0.02 to about 0.5 mg/cm2, more preferably still from about 0.05 to about 0.1 mg/cm2. The period of injections would be over a period of from about one month to the life of the subject, more preferably, in the case of humans, from about 1 month to about ten years, more preferably from about three months to about two years, more preferably still from about six months to about one year, thereby resulting in regulation of hair growth.
A more preferred method of applying the compositions according to the subject invention involves topical application to the scalp of a human subject or the skin of a domesticated animal subject to regulate hair growth, particularly where the scalp/skin is already bald or balding. The amount of the composition and the frequency of application to the hair and/or scalp/skin can vary widely, depending on the desired effect and/or personal needs, but it is suggested as an example that topical application preferably range from about 1 to about 10 times daily, more preferably from about 1 to about 6 times daily, more preferably still from about 1 to about 3 times daily, and most preferably about once per day.
The composition for topical application will preferably contain from about 0.01 to about 1,000 μg of dyphylline per cm2 skin receiving the topical composition, more preferably from about 0.1 to about 600 μg/cm2, more preferably still from about 1 to about 300 μg/cm2, more preferably from about 100 to about 300 μg/cm2. The period of topical application may be over the subject's life, but would preferably, in the case of a human subject, be over a period of from about one month to about ten years, more preferably from about three months to about two years, more preferably still from about six months to about one year, thereby resulting in regulation of hair growth.
In another embodiment of the subject invention, hair growth regulation is achieved by topical administration of a composition of the subject invention and oral administration of an antiandrogen (e.g., finasteride, cyproterone acetate) during the same treatment period.
The composition embodiments of the subject invention are illustrated in the following examples. All parts, percentages, and ratios used herein are by weight unless otherwise specified.
An injectable composition is prepared by combining the following components utilizing conventional mixing techniques.
______________________________________
Example No.
Component 23
______________________________________
Dyphylline 2.0
Sodium chloride 0.9
Sterile water for injection, USP
q.s. to 100%
______________________________________
0.1 cc of the composition per cm2 skin is injected at the site of desired hair regulation once every two weeks for six months to a subject resulting in new hair growth.
The following topical solutions are prepared by combining the following components utilizing conventional mixing techniques.
______________________________________
Example No.
Component 24 25 26
______________________________________
Dyphylline 0.01 1.00 5.00
N-octyl pyrrolidone
1.00 3.00 5.00
Perfume 1.00 1.00 1.00
Dimethyl isosorbide
balance to 100%
______________________________________
1000 mg of the composition per 100 cm2 skin is topically applied twice per day for one year to a subject resulting in new hair growth.
The following conditioning lotions are prepared by combining the following components utilizing conventional mixing techniques.
______________________________________
Example No.
Component 27 28 29
______________________________________
Dyphylline 0.01 1.00 5.00
Ammonium laureth sulfate
6.00 6.00 6.00
Disodium cocoamphodiacetate
3.00 3.00 3.00
Alkyl polyglucosides 2.70 2.70 2.70
Glycerine 5.00 5.00 5.00
Dimethicone copolyol 2.00 2.00 2.00
Polyol alkoxy ester 1.20 1.20 1.20
Polyquat 10 1.00 1.00 1.00
Sodium benzoate 0.25 0.25 0.25
DNMM hydantoin* 0.14 0.14 0.14
Disodium EDTA** 0.13 0.13 0.13
Mineral oil 4.00 4.00 4.00
Myristic acid 1.10 1.10 1.10
Polyethylene glycol caprylic/capric
2.00 2.00 2.00
glycerides
Titanium doxide 0.10 0.10 0.10
Perfume 1.00 1.00 1.00
Water balance to 100%
______________________________________
*1,3-dihydroxymethyl-3,3-dimethyl hydantoin
**ethylenediaminetetraacetic acid
1000 mg of the composition per 100 cm2 skin is topically applied once per day for 6 months to a subject resulting in prevention of hair loss.
The following shampoo compositions are prepared by combining the following components utilizing conventional mixing techniques.
______________________________________
Example No.
Component 30 31 32
______________________________________
Dyphylline 0.01 1.00 5.00
Ammonium laureth sulfate
6.00 6.00 6.00
Disodium cocoamphodiacetate
3.00 3.00 3.00
Alkyl polyglucosides
2.70 2.70 2.70
Glycerine 5.00 5.00 5.00
Dimethicone copolyol
2.00 2.00 2.00
Polyol alkoxy ester
1.20 1.20 1.20
Polyquat 10 1.00 1.00 1.00
Sodium benzoate 0.25 0.25 0.25
DMDM hydantoin* 0.14 0.14 0.14
Disodium EDTA** 0.13 0.13 0.13
Titanium dioxide 0.10 0.10 0.10
Perfume 1.00 1.00 1.00
Water balance to 100%
______________________________________
*1,3-dihydroxymethyl-3,3-dimethyl hydantoin
**ethylenediaminetetraacetic acid
This composition may be used in a conventional manner for cleaning hair, while bestowing hair growth regulation to the subject. From about 0.1 g to about 10 g of the composition is applied to hair that has been wetted, generally with water, worked through the hair and then rinsed out.
While particular embodiments of the subject invention have been described, it will be obvious to those skilled in the art that various changes and modifications of the subject invention can be made without departing from the spirit and scope of the invention. It is intended to cover, in the appended claims, all such modifications that are within the scope of the invention.
The following topical solutions are prepared by combining the following components utilizing conventional mixing techniques.
______________________________________
Example No.
Component 33 34 35
______________________________________
Dyphylline 1.00 3.00 5.00
Propylene glycol
49.00 47.00 35.00
Ethanol 30.00 30.00 30.00
Water 20.00 20.00 30.00
______________________________________
1000 mg of the composition per 100 cm2 of skin is topically applied once per day for six months to a subject resulting in new hair growth.
The following vanishing creams are prepared by combining the following components utilizing conventional mixing techniques.
______________________________________
Example No.
Component 36 37 38 39
______________________________________
Dyphylline 3.00 3.00 3.00 3.00
Stearic acid 13.00 7.00 14.00
Stearyl alcohol 1.00 5.00
Cetyl alcohol 1.00 2.00 2.00
Glyceryl monostearate 10.00
Isopropyl palmitrate 2.00
Lanolin 2.00
Methyl paraben 0.10 0.10 0.10 0.10
Sorbitan monostearate 2.00
Potassium hydroxide
0.90
Sodium lauryl sulfate 1.00
Polysorbate 60 1.50
Stearyl colamino formyl 1.50
methyl pyridinium chloride
Water q.s. to 100%
______________________________________
1000 mg of the composition per 100 cm2 skin is topically applied twice per day for six months to a subject resulting in new hair growth.
The following penetrating creams are prepared by combining the following components utilizing conventional mixing techniques.
______________________________________
Example No.
Component 40 41 42
______________________________________
Dyphylline 0.01 1.00 5.00
Cetearyl alcohol 5.00 5.00 5.00
Silicone oil, 200 fluid
1.00 1.00 1.00
Isopropyl myristate
2.00 2.00 2.00
Sodium stearoyl-2-lactylate
2.00 2.00 2.00
Propylene glycol 5.00 5.00 5.00
Sodium citrate 0.2 0.2 0.2
Preservative q.s. q.s. q.s.
Water q.s. to 100
______________________________________
1000 mg of the composition per 100 cm2 ski is topically applied once per day for one year to a subject resulting in new hair growth.
The following ion pair oil-in-water emulsions are prepared by combining the following components utilizing conventional mixing techniques.
______________________________________
Example No.
Component 43 44 45
______________________________________
Dyphylline 0.01 1.00 5.00
Pemuten Tr-2 0.30 0.30 0.30
Distearyl dimethyl ammonium chloride
0.15 0.15 0.15
Mineral oil 6.0 6.0 6.0
Dimethyl isosorbide 6.0 6.0 6.0
Dioctyl malate 6.0 6.0 6.0
Cetyl alcohol 1.0 1.0 1.0
Stearyl alcohol 1.0 1.0 1.0
Triethanolamine 0.50 0.50 0.50
Water q.s. to 100
______________________________________
1000 mg of the composition per 100 cm2 of the skin is topically applied twice per day for six months to a subject resulting in new hair growth.
The following liposomal dispersions are prepared by combining the following components utilizing conventional mixing techniques.
______________________________________
Example No.
Component 46 47
______________________________________
Dyphylline 5.00 5.00
Phosphatidyl choling (soy)
5.00
Cholesterol 0.5 1.00
Polyoxyethylene cetylether 5.00
Polyoxyehtylene cetyl amine 5.00
Alpha-tocapherol 1.0
EDTA 0.1 0.1
Water q.s. to 100
______________________________________
The reagents are blended to produce unilamillar or multilamellar vesicles by methods known to those skilled in the art. The resulting dispersions are either directly applied topically to the scalp (100 mg of composition per 100 cm2 of skin) or are blended into a suitable oil-in-water emulsion carrier, e.g, those in Examples V-VII, XIV, XVI, XVIII-XX at a level of about 1-25% (w/w) and then applied topically to the scalp at a comparable dosage level.
Claims (17)
1. A method of regulating hair growth in mammals comprising applying to a mammal in need of treatment a composition comprising:
a) a safe and effective amount of dyphylline, having the structure: ##STR2## or a pharmaceutically-acceptable salt thereof; and b) a carrier.
2. The method of claim 1 wherein application of the composition is by subcutaneous injection.
3. The method of claim 1 wherein application of the composition is topical.
4. The method of claim 3 wherein the amount of dyphylline applied to the skin is from about 0.01 μg per cm2 skin to about 600 μg per cm2 skin.
5. The method of claim 4 wherein the amount of dyphylline applied to the skin is from about 0.1 μg per cm2 skin to about 600 μg per cm2 skin.
6. The method of claim 4 wherein the amount of dyphylline applied to the skin is from 1 μg per cm2 skin to about 300 μg per cm2 skin.
7. A fluid dispensing device comprising:
a) a fluid container with a mouth;
b) a soft, porous-tipped applicator at an end of the fluid container;
c) a means for holding the applicator in the mouth of the container; and
d) a liquid composition deliverable from the fluid container through the applicator onto the skin, comprising from about 0.005% to about 15% of a compound having the structure: ##STR3## or a pharmaceutically-acceptable salt thereof.
8. The device of claim 7 wherein the liquid composition further comprises a phosphodiesterase inhibitor.
9. The device of claim 7 wherein the liquid composition comprises from about 1% to about 3% of dyphylline.
10. The device of claim 7 wherein the liquid composition further comprises cyclic adenosine monophosphate or a derivative thereof.
11. The method of claim 1 wherein the composition comprises a topical carrier comprising an emollient.
12. The method of claim 1 wherein the composition comprises from about 0.005% to about 15% dyphylline.
13. The method of claim 1 wherein the topical carrier further comprises glycerine.
14. The method of claim 13 wherein the topical carrier comprises from about 45% to about 85% water.
15. The method of claim 14 wherein the composition comprises from about 1% to about 10% dyphylline.
16. The method of claim 15 wherein the composition comprises from about 1% to about 5% dyphylline.
17. A topical composition for regulating hair growth in mammalian skin comprising:
a) a safe and effective amount of dyphylline having the structure: ##STR4## or a pharmaceutically-acceptable salt thereof; and b) a topical carrier comprising finasteride.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/164,600 USH1480H (en) | 1993-12-09 | 1993-12-09 | Methods of using dyphylline for the promotion of hair growth |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/164,600 USH1480H (en) | 1993-12-09 | 1993-12-09 | Methods of using dyphylline for the promotion of hair growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| USH1480H true USH1480H (en) | 1995-09-05 |
Family
ID=22595225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US08/164,600 Abandoned USH1480H (en) | 1993-12-09 | 1993-12-09 | Methods of using dyphylline for the promotion of hair growth |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | USH1480H (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262122B1 (en) * | 1997-08-13 | 2001-07-17 | Bristol-Myers Squibb Company | Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile |
| US20020192177A1 (en) * | 1998-10-26 | 2002-12-19 | A. Aoki, Ishida & Associates | Hair tonic composition |
| WO2004004672A1 (en) * | 2002-07-05 | 2004-01-15 | Unilever N.V. | Hair treatment compositions containing xanthine and alpha hydroxy acid |
| US6827942B2 (en) * | 2000-12-04 | 2004-12-07 | Colgate-Palmolive Co. | Composition and method of use |
| WO2005000241A3 (en) * | 2003-06-23 | 2005-11-17 | Macrochem Corp | Compositons and methods for topical administration |
| WO2007076993A1 (en) * | 2005-12-23 | 2007-07-12 | Aplagen Gmbh | Process for forming disulphide bridges |
| WO2008077621A1 (en) * | 2006-12-23 | 2008-07-03 | Aplagen Gmbh | Method for forming disulfide bridges |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4341783A (en) * | 1980-07-31 | 1982-07-27 | Lemmon Company | Topical use of dyphylline and dyphylline containing compositions |
| JPS6245527A (en) * | 1985-08-21 | 1987-02-27 | Shiseido Co Ltd | Preventive and remedy for gray hair |
| DE3801034A1 (en) * | 1988-01-15 | 1989-07-27 | Wolff Chem Pharm Gmbh | HAIR AND SCALP TREATMENT |
| DE3913245A1 (en) * | 1988-04-23 | 1989-11-02 | Toyama Chemical Co Ltd | PYRIDONE CARBONIC ACID DERIVATIVES AND THE SALTS THEREOF, METHOD FOR THE PRODUCTION THEREOF AND ANTIBACTERIAL AGENTS WITH A CONTENT THEREOF |
-
1993
- 1993-12-09 US US08/164,600 patent/USH1480H/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4341783A (en) * | 1980-07-31 | 1982-07-27 | Lemmon Company | Topical use of dyphylline and dyphylline containing compositions |
| JPS6245527A (en) * | 1985-08-21 | 1987-02-27 | Shiseido Co Ltd | Preventive and remedy for gray hair |
| DE3801034A1 (en) * | 1988-01-15 | 1989-07-27 | Wolff Chem Pharm Gmbh | HAIR AND SCALP TREATMENT |
| DE3913245A1 (en) * | 1988-04-23 | 1989-11-02 | Toyama Chemical Co Ltd | PYRIDONE CARBONIC ACID DERIVATIVES AND THE SALTS THEREOF, METHOD FOR THE PRODUCTION THEREOF AND ANTIBACTERIAL AGENTS WITH A CONTENT THEREOF |
Non-Patent Citations (8)
| Title |
|---|
| Imokawa, G., Y. Yada, and Y. Hori., "Induction of Melanization Within Hair Bulb Melanocytes in Chinchilla Mutant by Melanogenic Stimulants", Society for Investigative Dermatology, Inc., vol. 91(2), pp. 106-113 (1988). |
| Imokawa, G., Y. Yada, and Y. Hori., Induction of Melanization Within Hair Bulb Melanocytes in Chinchilla Mutant by Melanogenic Stimulants , Society for Investigative Dermatology, Inc., vol. 91(2), pp. 106 113 (1988). * |
| Seiler, W. G., "Possibilities of Preserving Hair Growth and of Controlling Dandruff and Seborrhoea in the Region of the Capillitium", Akt. Derm. vol. 7, pp. 51-59 (1981). |
| Seiler, W. G., E. Bohnert, E. G. Jung, and U. Feldmann. "Local Therapy in Androgenically Caused Hair Loss", Artzliche Kosmetologie vol. 14, pp. 209-220 (1984). |
| Seiler, W. G., E. Bohnert, E. G. Jung, and U. Feldmann. Local Therapy in Androgenically Caused Hair Loss , Artzliche Kosmetologie vol. 14, pp. 209 220 (1984). * |
| Seiler, W. G., Possibilities of Preserving Hair Growth and of Controlling Dandruff and Seborrhoea in the Region of the Capillitium , Akt. Derm. vol. 7, pp. 51 59 (1981). * |
| Stuttgen, C., and D. Neumann, "Caffein and Skin", Aztliche Kosmetologie vol. 19, pp. 163-187 (1980). |
| Stuttgen, C., and D. Neumann, Caffein and Skin , Aztliche Kosmetologie vol. 19, pp. 163 187 (1980). * |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262122B1 (en) * | 1997-08-13 | 2001-07-17 | Bristol-Myers Squibb Company | Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile |
| US20020192177A1 (en) * | 1998-10-26 | 2002-12-19 | A. Aoki, Ishida & Associates | Hair tonic composition |
| US7182939B2 (en) * | 1998-10-26 | 2007-02-27 | Shiseido Company, Ltd. | Hair tonic composition |
| US20070116658A1 (en) * | 1998-10-26 | 2007-05-24 | Shiseido Company, Ltd. | Hair tonic composition |
| US6827942B2 (en) * | 2000-12-04 | 2004-12-07 | Colgate-Palmolive Co. | Composition and method of use |
| WO2004004672A1 (en) * | 2002-07-05 | 2004-01-15 | Unilever N.V. | Hair treatment compositions containing xanthine and alpha hydroxy acid |
| US7871599B2 (en) | 2002-07-05 | 2011-01-18 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Hair treatment compositions containing xanthine and alpha hydroxy acid |
| WO2005000241A3 (en) * | 2003-06-23 | 2005-11-17 | Macrochem Corp | Compositons and methods for topical administration |
| WO2007076993A1 (en) * | 2005-12-23 | 2007-07-12 | Aplagen Gmbh | Process for forming disulphide bridges |
| US20090081145A1 (en) * | 2005-12-23 | 2009-03-26 | Aplagen Gmbh | Process for forming disulphide bridges |
| WO2008077621A1 (en) * | 2006-12-23 | 2008-07-03 | Aplagen Gmbh | Method for forming disulfide bridges |
| US20100203001A1 (en) * | 2007-07-11 | 2010-08-12 | Aplagen Gmbh | Process for forming disulfide bridges |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7001594B1 (en) | Scalp cosmetic compositions and corresponding methods of application to provide scalp moisturization and skin active benefits | |
| CN1315454C (en) | Topical compositions for regulating oily/shiny appearance of skin | |
| US5362748A (en) | Methods of using diethyldithiocarbamic acid for the prevention of hair growth | |
| WO2002032381A2 (en) | Packaged scalp cosmetic compositions | |
| CA2277946A1 (en) | Persistent hair tonic | |
| IL132625A (en) | Composition for inducing hair growth | |
| USH1480H (en) | Methods of using dyphylline for the promotion of hair growth | |
| JP3220761B2 (en) | Hair restoration | |
| US5344651A (en) | Cyproterone acetate thioacetate | |
| JPH11269043A (en) | Cosmetic for scalp and hair | |
| JPH11269042A (en) | Cosmetic for scalp and hair | |
| US5976515A (en) | Blood flow amount-improving agent comprising steroid derivative and cosmetic using same | |
| JP2002080327A (en) | Hair grower | |
| JPH10279437A (en) | Hair cosmetic | |
| JPH11302133A (en) | Cosmetic for scalp and hair | |
| US5439901A (en) | Cyproterone thiopivalate | |
| JPH11302131A (en) | Cosmetic for scalp and hair | |
| JP2002520375A (en) | Ingredients containing triterpenes for hair growth control | |
| JPH01135711A (en) | Hair tonic | |
| JPH0640858A (en) | Hair tonic | |
| JPH11255621A (en) | Cosmetic for scalp and hair | |
| JPH07206647A (en) | Hair tonic | |
| JPH11263714A (en) | Cosmetic for scalp and hair of head | |
| JPH07149614A (en) | Hair tonic agent | |
| JPH11302128A (en) | Cosmetic for scalp and hair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |